PRSS50 and metastatic malignant neoplasm in the lymph nodes: There was no significant association between TSP50 expression status in CRCs and all the clinicopathologic features including age, sex, depth of invasion, lymph node metastasis, and tumor location, size, stage and grade (Table 2).